(Q39458040)

12 September 2017

title

Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma (English)

1 reference

12 September 2017

Aws Alshamsan

1

1 reference

12 September 2017

publication date

15 October 2011

1 reference

Immunopharmacology and Immunotoxicology

12 September 2017

published in

1 reference

12 September 2017

volume

34

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

465-469

1 reference

Hallmarks of Cancer: The Next Generation

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Harnessing dendritic cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Targeting of Jak/STAT pathway in antigen presenting cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Mechanisms of disease: Insights into the emerging role of signal transducers and activators of transcription in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

STAT3: a critical transcription activator in angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Role of Stat3 in suppressing anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Elevated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Role of dendritic cells in the induction of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Cell biology of antigen processing in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Tumour escape from immune surveillance through dendritic cell inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Co-operative action of interleukin-10 and interferon-gamma to regulate dendritic cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Selective expansion of foxp3-positive regulatory T cells and immunosuppression by suppressors of cytokine signaling 3-deficient dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

Induction of potent antitumor immunity by in situ targeting of intratumoral DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08923973.2011.625034

10.3109/08923973.2011.625034

21 January 2018

Identifiers

DOI

1 reference

12 September 2017

1 reference